neostigmine has been researched along with Diseases, Metabolic in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MARTIN, GJ | 1 |
| Bräutigam, HH | 1 |
| Netter, KJ | 1 |
| Rietbrock, N | 1 |
2 other studies available for neostigmine and Diseases, Metabolic
| Article | Year |
|---|---|
The action of prostigmine in the nutritional muscular dystrophy of vitamin E deficiency.
Topics: Humans; Metabolic Diseases; Minerals; Muscular Dystrophies; Neostigmine; Vitamin E; Vitamin E Defici | 1946 |
[Postoperative apnea after suxamethonium].
Topics: Adult; Apnea; Bis-Trimethylammonium Compounds; Blood Transfusion; Cholinesterases; Female; Humans; M | 1966 |